Podcast appearances and mentions of jeff borghoff

This 5 minute podcast summarizes what you can expect at the Patients as Partners US conference. This is the only event in R&D that truly demonstrates how to involve patients throughout the entire medicines development life cycle to drive greater efficiencies in clinical research. The 7th annual Patients as Partners US program features the following key topic areas: BioPharma Strategies on Applying Patient Engagement Initiatives and Demonstrating ImpactDirect-to-Patient Clinical Trials Next Milestones and Actions to Get ThereMeasuring the Impact of Patient Engagement and Patient Centricity in Clinical Research and DevelopmentCurrent Efforts for Educating and Enrolling Diverse Populations in Clinical TrialsProgress on Patient Data OwnershipCollaborating with Site Partners & CROs to Increase Efficiencies, Provide Greater Value to Patients and Clinical TrialsProgress on the National Health Council’s Patient Engagement Fair Market Value InitiativeFDA Reports on the Latest Guidance Updates and New Agency Efforts on Patient Engagement Keynotes include: Jeff Borghoff, Alzheimer's Patient and AdvocateChip Bell, Customer Service GuruDr Joanne Waldstreicher, Johnson & JohnsonDr Darryl Sleep, AmgenKen Getz, CISCRP/Tufts CSDD Patients as Partners US takes place June 29-30, 2020 at the Hilton Philadelphia at Penn's Landing, Philadelphia, PA. For more information please visit www.patientsaspartners.org

Biogen has announced new data behind the Alzheimer's drug aducanumab, suggesting it was working on early stage patients. Jeff Borghoff was a participant for three years before the company halted the stage three clinical trial. He talks to Being Patient Alzheimer's about why he felt the drug was working.

Pharma Talk Radio producer, Valerie Bowling recently spoke with a young Alzheimer's patient, Jeff Borghoff. Jeff was officially diagnosed with Alzheimers in 2016 and is an active and patiionate patient advocate. Jeff generously shares his experience from diagnosis, to the experience of a clinical trial to his work in advocacy. Jeff will be speaking at the Patients as Partners conference on June 29-30, 2020 in Philadelphia. For more information, visit theconferenceforum.org We look forward to bringing you more podcasts featuring patient advocates and more on the topic of dementia. Resources that Jeff recommends: Alzherimer's AssociationAlzheimer's Congressional TeamAlzheimer's Association Early-Stage Advisory Group

Jeff Borghoff and his wife Kimberly speak about participating in the Biogen drug trial testing aducanumab, a drug that targets beta-amyloid. The late-stage trial was recently canceled, news that sent participants, their families, researchers and stocks reeling.

We all know how difficult caregiving for a loved one with dementia can be. Imagine finding out you have Alzheimer’s too. Being Patient speaks to Jeff Borghoff about receiving a diagnosis at 51 years old.

Today we are lucky to have Jeff Borghoff with us. Jeff was diagnosed in March of 2016 at the age of 51 with Early-Stage (or younger onset) Alzheimer's Disease.   Since than he has been working with great fervor with the National Alzheimer's Association as a member of the National Early-Stage Advisory Group and with the Alzheimer's Association Greater NJ Chapter.  Today we will talk to Jeff and learn about his struggles triumphs and passions. Contact Information For http://www.borghoff.com http://twitter.com/Jeff_Borghoff      jeff.borghoff@borghoff.com  Additional Resource Information: Alzheimer's Speaks Resource Website: https://www.alzheimersspeaks.com/ Keynote Speaker: https://www.alzheimersspeaks.com/event-planners Dementia Chats™: https://www.alzheimersspeaks.com/dementia-chats-webinar Conscious Caring Resources: https://www.alzheimersspeaks.com/conscious-caring-resources Become Dementia Friendly Business or Community: https://www.alzheimersspeaks.com/become-dementia-friendlySupport this Show: https://alzheimersspeaks.com/donate-now/See omnystudio.com/listener for privacy information.